Adrenergic receptor function in panic disorder -: I.: Platelet α2 receptors:: Gi protein coupling, effects of imipramine, and relationship to treatment outcome

被引:16
作者
Gurguis, GNM
Antai-Otong, D
Vo, SP
Blakeley, JE
Orsulak, PJ
Petty, F
Rush, AJ
机构
[1] Dept Vet Affairs Med Ctr, Dallas, TX USA
[2] Univ Texas, SW Med Sch, Dallas, TX 75230 USA
关键词
alpha2-adrenergic receptors; G protein; coupling; panic disorder; anxiety; depression;
D O I
10.1016/S0893-133X(98)00062-1
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Various studies suggest alpha(2)-adrenergic receptor (alpha(2)AR) dysregulation in panic disorder (PD). Platelet alpha(2)-AR exist in high- and low-conformational states as a function of their coupling to G(i) protein, alpha(2)-AR coupling is important in signal transduction and is modulated by antidepressants. alpha(2)AR density in the high- and low-conformational states, agonist affinity, and coupling efficiency were investigated in 21 healthy controls, 21 drug-free PD patients, and eight imipiramine-treated patients using norepinephrine displacement of H-3-yohimbine binding. Percentage of receptors in the high-conformational state (%R-H) and the ratio of the agonist dissociation constant to the receptor in the low-/high-conformational state (K-L/K-H), calculated from displacement experiments, were used as coupling indices. Patients had high alpha(2)AR density in both conformational states. %R-H and K-L/K-H ratio were significantly different, particularly in patients with Hamilton scale for depression (HAMD) scores greater than or equal to 15, Imipramine treatment (29 weeks) had no effect on alpha(2)AR density or coupling, despite improvement in anxiety ratings. High pretreatment alpha(2)AR density and coupling predicted low severity of anxiety after treatment. Increased alpha(2)AR density and abnormal coupling may represent an adaptive mechanism or trait marker in PD. [Neuropsychopharmacology 20:162-276, 1999] (C) 1998 American College of Neuropsychopharmacology.
引用
收藏
页码:162 / 176
页数:15
相关论文
共 106 条
[1]   ENDOCRINE, CARDIOVASCULAR, AND BEHAVIORAL-RESPONSES TO CLONIDINE IN PATIENTS WITH PANIC DISORDER [J].
ABELSON, JL ;
GLITZ, D ;
CAMERON, OG ;
LEE, MA ;
BRONZO, M ;
CURTIS, GC .
BIOLOGICAL PSYCHIATRY, 1992, 32 (01) :18-25
[2]   MEASUREMENT OF FEELINGS USING VISUAL ANALOGUE SCALES [J].
AITKEN, RCB .
PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1969, 62 (10) :989-+
[3]   A STUDY OF 2 FACTORS WHICH AFFECT AROUSAL LEVEL AND APPARENT DURATION OF A 10-MINUTE INTERVAL [J].
AITKEN, RCB ;
GEDYE, JL .
BRITISH JOURNAL OF PSYCHOLOGY, 1968, 59 :253-+
[4]  
ALBUS M, 1986, CLIN NEUROPHARMACOL, V9, P359
[5]   ANXIOGENIC PROPERTIES OF YOHIMBINE .1. BEHAVIORAL, PHYSIOLOGICAL AND BIOCHEMICAL MEASURES [J].
ALBUS, M ;
ZAHN, TP ;
BREIER, A .
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 1992, 241 (06) :337-344
[6]  
[Anonymous], 1987, DIAGNOSTIC STAT MANU, V4th
[7]  
[Anonymous], 1970, SELF EVAL QUEST
[8]  
BHATIA SC, 1991, RES COMMUN CHEM PATH, V74, P47
[9]   THE ADRENALINE - ALPHA-2-ADRENOCEPTOR-MEDIATED VASOCONSTRICTOR AXIS [J].
BOLLI, P ;
ERNE, P ;
KIOWSKI, W ;
AMMAN, FW ;
BUHLER, FR .
CLINICAL SCIENCE, 1985, 68 :S141-S146
[10]   THE GALWAY STUDY OF PANIC DISORDER .2. CHANGES IN SOME PERIPHERAL MARKERS OF NORADRENERGIC AND SEROTONERGIC FUNCTION IN DSM III-R PANIC DISORDER [J].
BUTLER, J ;
OHALLORAN, A ;
LEONARD, BE .
JOURNAL OF AFFECTIVE DISORDERS, 1992, 26 (02) :89-100